Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Public Voting Now Open for MedVet’s Shelter Surprise to Award Funds to Local Shelters


MedVet Shelter Surprise Voting is Live

MedVet Shelter Surprise Voting is Live

Many shelters and rescues have a great need for support, so we are excited to be able to raise awareness for them while also offering some funds to cover some of their expenses.

Voting is now open for MedVet’s Shelter Surprise contest which will award three deserving shelters cash prizes to support the important work they do to save pets. Out of hundreds of nominations, 10 animal shelter and rescue organizations were chosen, and it’s now up to the public to decide which organization will receive cash prizes.    

“We are honored to collaborate with many animal shelters and rescues that are working to save pets and place them with loving families,” said Dr. Linda Lehmkuhl, Chief Executive Officer of MedVet. “These facilities are typically under-resourced for the important work they are doing. Many shelters and rescues have a great need for support, so we are excited to be able to raise awareness for them while also offering some funds to cover some of their expenses.”

Throughout September and October, individuals nominated deserving shelters and rescues for the contest, and now the public is invited to cast their votes for the organization they would like to see win the top prize. Voting is open from Oct. 24-Nov. 4. The organization with the most votes will receive $2,000, the second-place organization will receive $1,250, and a third winner will receive $500. Winners will be announced during National Animal Shelter and Rescue Appreciation Week, which takes place Nov. 6-13.

The 10 finalist organizations are:

  • Asheville Humane Society in Asheville, NC
  • Cincinnati Animal CARE in Cincinnati, OH
  • Dallas Dog RRR in Dallas, TX
  • For the Love of Cats in Commerce, MI
  • Meridian Canine Rescue in Meridian, ID
  • Northshore Humane Society in Covington, LA
  • Paws Up 4 Rescue in Joliet, IL
  • Project Precious Rescue in Stamford, CT
  • Stop the Suffering in Columbus, OH
  • West Valley City Animal Shelter in West Valley, UT

Find more information about the contest and vote for your favorite shelter or rescue here.

About MedVet:

MedVet is the leading veterinarian owned and led family of specialty and emergency hospitals and urgent cares dedicated to delivering exceptional care and a deeply supportive experience to pets and their loving families, referring veterinarians, and team members. For more than 30 years, MedVet’s empathetic, insightful, and driven team of expert caregivers has helped the organization grow to be the preferred choice for high quality, compassionate care, proudly serving more than 500,000 patients each year in communities throughout the United States. To learn more about MedVet and its mission of Leading Specialty Healthcare for Pets, visit medvet.com. 

###

Share article on social media or email:

Allegheny Health Network Cardiovascular Institute First in Pittsburgh to Implant Groundbreaking Neuromodulation Device as Alternative Therapy for Heart Failure Patients


News Image

“Today’s announcement is an exciting milestone for our heart failure patients…it provides another novel approach that is proven to minimize heart failure’s damaging effects and restore a patient’s overall quality of life,” — Dr. Satish Muluk, director of AHN Division of Vascular Surgery.

Vascular surgeons from Allegheny General Hospital (AGH) Cardiovascular Institute, the flagship academic medical center of Allegheny Health Network (AHN), announced today the first successful implant of a new neuromodulation device used as an alternative therapy for patients with progressive heart failure (HF) who may not be receiving adequate relief from medical therapies.

The device, titled Barostim™ Baroreflex Activation Therapy, is from Minneapolis-based med tech company CVRx and is the world’s first FDA-approved HF device to use manipulation of the nervous system to reinvigorate the heart and improve its function.

The implant procedure took place in early September under the clinical direction of Satish Muluk, MD, vascular surgeon and director of AHN Division of Vascular Surgery and Srinivas Murali, MD, heart failure specialist and System Chairman of the AHN Department of Cardiovascular Medicine.

“Heart failure is a condition that causes the muscle in the heart wall to slowly weaken and enlarge, preventing the heart from pumping enough oxygenated blood throughout the body,” explained Dr. Muluk. “The symptoms of heart failure are often progressive, and the condition can worsen on medical therapy alone. Today’s announcement is an exciting milestone for our heart failure patients throughout western Pennsylvania as it provides another novel approach that is proven to minimize heart failure’s damaging effects and restore a patient’s overall quality of life.”

According to the American Heart Association, heart failure is one of the most common reasons people over the age of 65 are admitted to the hospital. It’s a chronic condition with symptoms ranging from shortness of breath and extreme fatigue to lightheadedness and fluid retention, among others.

Approximately six million Americans are currently living with heart failure and research indicates the number of individuals living with cardiovascular disease will likely surge to 12.9 million by 2060. From a local perspective, the leading cause of death in Allegheny County is heart disease, above cancer, accidental injuries and cerebrovascular disease. Furthermore, heart disease in the Greater Pittsburgh population tracks notably higher than the state average, according to the PA Department of Health.

To date, the prescribed course of management involves a multidisciplinary approach involving medical therapies, lifestyle enhancements and surgical interventions ranging from minimally invasive implantations of pacemakers and defibrillators to more aggressive management paths of open-heart surgery to implant a left-ventricular assist device (LVAD) or heart transplantation.

Unlike other HF treatment options, Barostim does not require any hardware implantation in the heart but uses an electrode that’s placed on the patient’s carotid artery within the neck during a minimally-invasive outpatient procedure. The electrode provides continuous electrical stimulation to the body’s carotid baroreceptors, the body’s natural mechanism that regulates cardiovascular function.

Barostim’s stimulation triggers both the body’s sympathetic (“fight or flight” response) and parasympathetic (“rest and digest” response) nervous systems to create a unique balance that in turn better regulates the function of a patient’s heart, kidney and vascular system.

“Unlike a pacemaker, Barostim stimulates the nervous system to address a neuro-hormonal imbalance which is the root cause of heart failure. In many instances, the baroreceptors in heart failure patients have lost their vigor and so this device kick starts the nervous system into high gear restoring neuro-hormonal balance which in turn improves cardiovascular performance,” explained Dr. Murali. “Patients can go home on the same day as the procedure, and our team gradually adjusts the output of the device over the next few weeks to specifically tailor electrical stimulation to achieve optimal improvement of the patient’s symptoms.”

The Journal of the American College of Cardiology published a study (https://doi.org/10.1016/j.jacc.2020.05.015) from cardiovascular researchers demonstrating the overall effectiveness of Barostim in a controlled patient population living with heart failure and a reduced ejection fraction. Four patient cohorts were created from 408 randomized patients with select groups receiving baroreflex activation therapy and medical management or solely optimal medical management. Results showed Barostim patients were able to walk about 65 yards further in six minutes and had three times greater improvement in quality-of-life scores when compared to patients on medications alone.

“Providing innovative treatment options for heart failure patients is an important endeavor and we congratulate Drs. Muluk and Murali and Allegheny General Hospital on a successful Barostim implantation,” said Nadim Yared, President and CEO of CVRx. “We look forward to continuing to support Allegheny General Hospital to help more patients live fuller lives.”

For more information or to make an appointment with AHN Cardiovascular Institute, visit ahn.org.

###

About the Allegheny Health Network:

Allegheny Health Network (AHN.org) is an integrated healthcare delivery system serving the greater Western Pennsylvania region. The Network is composed of 14 hospitals, ambulatory surgery centers, Health + Wellness Pavilions, multiple employed physician organizations, home and community based health services, a research institute, and a group purchasing organization. The Network provides patients with access to a complete spectrum of advanced medical services, including nationally recognized programs for primary and emergency care, trauma care, cardiovascular disease, organ transplantation, cancer care, orthopedic surgery, neurology and neurosurgery, women’s health, diabetes, autoimmune disease and more. AHN employs approximately 21,000 people, has more than 2,600 physicians on its medical staff and serves as a clinical campus for Drexel University College of Medicine and the Lake Erie College of Osteopathic Medicine.

Share article on social media or email:

Santé Center for Healing’s Offers 3 Collegiate Scholarships


We offer these collegiate scholarships with the desire to assist individuals who are working to further their education. Helping individuals in recovery from addiction and/or specifically wanting to pursue a degree in these important fields aligns with Santé’s core values.

Three scholarship awards will benefit collegiate students wishing to further and advance their education, whether they are in recovery and/or pursuing careers in the mental and behavioral health fields.

“We offer these collegiate scholarships with the desire to assist individuals who are working to further their education. Helping individuals in recovery from addiction and/or specifically wanting to pursue a degree in these important fields aligns with Santé’s core values,” says CEO Sam Slaton, MEd, LPC-S, MBA, MHSM. “Providing assistance to those entering this field is a privilege.”

The award amount for each is $500 and recognizes three of Santé’s legacy makers:

  • The Rip Corley & Santé Center for Healing Scholarship in memory of Santé’s co-founder Rip Corley, LMSW, RN. This will go to an individual in recovery (2 year minimum) from addiction who has completed at least one year in college and pursuing an undergraduate degree from an accredited college and/or university.
  • The Dr. Deb Corley & Santé Center for Healing Scholarship in honor of Santé’s co-founder/co-owner M. Deborah Corley, PhD. This will go to an individual pursuing a graduate degree towards work in the mental and behavioral health field.
  • The Sam Slaton & Santé Center for Healing Scholarship in celebration of Santé’s CEO Sam Slaton, MEd, LPC-S, MBA, MHSM years of leadership. This will go to an individual pursuing a graduate degree towards health care management.

Submission and Award Details

Submission period: September 1, 2022 – December 5, 2022

Award Announcement: December 9, 2022

Award Date: December 21, 2022

In 2020, 73.8 million Americans (adults aged 18 or older) had a mental illness and/or substance use disorder in the past year.¹ It is vital to have qualified individuals in the fields of mental and behavioral health and health care management.

For more scholarship insights and eligibility requirements, click here.

About Santé Center for Healing: Santé Center for Healing provides integrity-driven, evidence-based, and personalized long-term recovery for those suffering from substance use disorders, mental health, trauma, problematic sexual behavior, co-occurring disordered eating and other compulsive behaviors. Santé was founded in 1996 and is celebrating more than 26 years of service. For more information, visit http://www.santecenter.com.

1. Substance Abuse and Mental Health Services Administration. (2021). Key substance use and mental health indicators in the United States: Results from the 2020 National Survey on Drug Use and Health (HHS Publication No. PEP21-07-01-003, NSDUH Series H-56). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data/

Share article on social media or email:

Ideal Option and Brick House Recovery to Co-Host Open House


Ideal Option, a national leader in outpatient medication-assisted treatment for addiction, and Brick House Recovery will co-host an open house in Coeur d’Alene on Friday, November 4, at 3918 N Schreiber Way.

“We appreciate the collaboration with Ideal Option to create synergy and address the opioid crisis, addiction and mental health challenges facing the Idaho Panhandle,” said Jason Coombs, CEO of Brick House Recovery. “Our mission is to provide exceptional and effective treatment for adults struggling with substance abuse and co-occurring disorders.”

Recipient of the 2022 Idaho’s Best in Mental Wellness award, Brick House Recovery offers a higher power-based family-centered approach to treatment and long-term recovery.

“At Ideal Option, we’re proud to embrace and collaborate with all providers of recovery services in the communities where we operate,” said Tim Kilgallon, CEO of Ideal Option. “Brick House Recovery is one of the best and most well-respected of those providers in Idaho, so we are thrilled to be sharing our space with them. We hope that this collaboration will encourage more people to take advantage of our combined services available in Coeur d’Alene.”

On Friday, November 4, from both 11 a.m. to 2 p.m. and 4 p.m. to 7p.m., all members of the community are invited to drop by the new clinic in Coeur d’Alene located at 3918 N Schreiber Way. A ribbon-cutting ceremony with the Coeur d’Alene Regional Chamber will take place at noon.

During the open house, attendees can tour the facility, pick up printed materials, meet Ideal Option and Brick House Recovery staff, enjoy refreshments, and grab one of 50 autographed copies of the #1 Amazon Best Seller: “Unhooked: How to Help an Addicted Loved One Recover,” by Jason Coombs.

For questions about this event, email Senior Marketing Manager Olivia Roe at oliviaroe@idealoption.net.

About Ideal Option

Headquartered in Kennewick, Washington, Ideal Option was founded in 2012 and has since helped more than 60,000 patients through a network of over 80 office-based medication-assisted treatment (MAT) clinics across 10 states. With a mission to serve under-served communities, Ideal Option accepts all forms of insurance including Medicaid and Medicare. Financial assistance and payment plans are also available.

Ideal Option’s team of medical providers carry certifications in Addiction and Emergency Medicine, Internal, and Family Medicine, among other specialties. The company also employs social workers, caseworkers, counselors, and mental health practitioners. This holistic approach helps drive positive outcomes, including family stability, stable housing, improved overall health, and reduced rates of recidivism.

In all the communities it serves, Ideal Option collaborates with existing stakeholders and providers to improve the continuum of care. This approach includes partnerships with emergency rooms and county jail systems, where individuals with substance use disorder often appear, as well as collaborating with numerous support agencies and municipal programs addressing social needs such as housing, mental health, and nutrition support.

About Brick House Recovery

For more information about Brick House Recovery, please contact Jason Coombs at jason@brickhouserecovery.com or visit their website at http://www.brickhouserecovery.com.

Share article on social media or email:

HARTMANN USA and Corstrata Collaborate to Improve Patient Wound Outcomes


HARTMANN USA and Corstrata announce their collaboration to support home health and other in-home providers in caring for wound patients at a time when the incidence of complex chronic wounds is increasing while access to wound care nurse specialists is becoming more challenging. At the core of a successful wound care program is access to both highly effective advanced wound dressings as well as clinical expertise to implement evidence-based treatment protocols and monitor wounds to closure. According to a recent study published by top-50 accounting firm BerryDunn, National Healthcare at Home Best Practices and Future Insights Study, 100% of Home Health Centers of Excellence (those Home Health agencies in the top 10% for quality and patient satisfaction and with a positive financial surplus) have a wound-certified specialist on staff.

This collaboration will increase access to Corstrata’s team of virtual board-certified wound nurses (WOC nurses) and HARTMANN’s suite of advanced wound care products to improve clinical and financial outcomes for in-home providers that care for patients with chronic wounds.

HARTMANN has been providing advanced wound dressing solutions globally for over 150 years and has evolved with its broad portfolio of high-quality, cost-effective products that provide home health clinicians with a simplified, consistent approach for effectively managing wounds. Corstrata provides virtual wound and ostomy care management nationwide across multiple provider settings, including home health, skilled nursing facilities, hospice, and emerging hospital-at-home solutions companies.

According to Jon Procopio, Managing Director of HARTMANN USA, “Patient care is our priority. HARTMANN strives to enable the progression of the wound towards complete healing that patients deserve and strengthen the confidence that healthcare professionals need to provide wound care. We have a nationwide team of dedicated account and customer care representatives specifically trained for consultation, education, and support in offering clinical and business solutions. Now, with Corstrata, we will enhance access to clinical expertise related to wound care through their team of certified WOC nurses.”

“The Corstrata team is excited about this important collaboration with HARTMANN to create access to Corstrata’s virtual WOC nurses for customers and the patients they serve. With up to one-third of all home health and hospice patients having a chronic wound, it is critical for clinicians to provide evidence-based care to both prevent and heal wounds,” says Joseph Ebberwein, co-founder and Chief Financial Officer of Corstrata. “At this time when agencies are struggling with critical staffing shortages, including WOC nurses, and increasing financial challenges, having a strong wound program is essential. This collaboration between Corstrata and HARTMANN provides a path to success.”

According to Katherine Piette, Corstrata’s CEO, the decision to collaborate with HARTMANN is an easy one. “Our virtual WOC nurses rely on our provider customers having access to highly effective advanced wound dressings to accelerate wound healing and reduce the overall cost of patient care, ” Piette says. “HARTMANN has a unique suite of advanced dressings that are being used by some of the top home health providers in the U.S. with impressive results. We are excited about the opportunity to improve the level of wound care provided for this ever-growing cohort of complex wound patients. Our clients can access clinical support from Corstrata when needed without the cost of hiring their own WOC nurse, a costly and often frustrating proposition. This collaboration will equip providers with turn-key wound solutions that they have been missing in their clinical care delivery at a crucial time in the industry.”

About HARTMANN

The HARTMANN GROUP is one of the leading providers of wound treatment and skin integrity solutions around the world. Wound dressings and maintaining healthy skin have been at the heart of HARTMANN from the beginning when we introduced the world’s first antiseptic wound dressing over 150 years ago. Overall, HARTMANN looks at rich legacy. Every day, healthcare professionals and patients rely on HARTMANN brands in the segments of Incontinence Management (e.g. MoliCare®), Wound Care (e.g. Zetuvit®) and Infection Management (e. g. Sterillium®). This is expressed in our brand promise of “Helps. Cares. Protects.” In 2021, the HARTMANN GROUP reported Group sales of EUR 2.3 billion.

For the latest information on HARTMANN, follow @HARTMANN_GROUP on Twitter.

To learn more about the HARTMANN GROUP, click here.

To learn more about HARTMANN USA, click here.

About Corstrata

Corstrata is a virtual care solution that utilizes technology to provide access to scarce certified wound and ostomy nurses at the patient’s bedside in post-acute provider settings, including home health, hospice, skilled nursing facilities, and emerging hospital-at-home providers. Corstrata’s team of WOC nurses provides consultations with provider staff at the patient’s bedside, either through HIPAA-compliant video or through review of store-and-forward wound images, to improve clinical and financial outcomes for providers.

For the latest information on Corstrata, follow @Corstrata on Twitter.

To learn more about Corstrata, click here.

Share article on social media or email:



Dr. Gary Motykie Wins Best Botched Patient Enhancement at the 2022 Aesthetic Awards


Approximately half of the cases I perform are revising other surgeons’ work. To be recognized for my ability to perform revision plastic surgery is an honor.

Beverly Hills board-certified plastic surgeon, Dr. Gary Motykie, has won Best Botched Patient Enhancement at the 2022 Aesthetic Awards.

“Being selected as a winner in the Botched Revision category is especially exciting for me because you have to earn a previously ‘botched’ patient’s trust and confidence in order to perform their revision surgery,” says Dr. Motykie. “Approximately half of the cases I perform are revising other surgeons’ work. To be recognized for my ability to perform revision plastic surgery is an honor.”

“No patient wants to have to go through with revision plastic surgery. I know the process can be intimidating,” added Dr. Motykie. “I’m so grateful that I can be the surgeon that can help patients achieve the results they truly desired from their initial surgery.”

Dr. Motykie’s state-of-the-art office, on-site surgical center, and medical spa are at 9201 W. Sunset Blvd, GF-1A in West Hollywood. Dr. Motykie is known for pioneering facial rejuvenation surgery and natural-appearing body enhancement surgery.

“This year my team and I have narrowed in on promoting extraordinary outcomes by incorporating stem cells into the recovery process for patients. I believe stem cells make recovering from revision surgery easier on the patient.”

Dr. Motykie recently joined TikTok – he regularly uploads videos about plastic surgery trends, speculates on celebrity plastic surgery, and discusses plastic surgery procedures. He has amassed more than 4 million views in less than one month.

In addition to his West Hollywood flagship location, Dr. Motykie owns a medical spa, Motykie Med Spa Barrington, in the northwest Chicago suburb of Barrington, Illinois.

About Dr. Gary Motykie:

Dr. Gary Motykie is a Board-Certified Plastic Surgeon who is highly skilled in breast surgery, body contouring, rhinoplasty, and facial rejuvenation as well as numerous other cosmetic surgical procedures. Dr. Motykie has more than 50,000 subscribers on YouTube where he uploads videos discussing celebrity plastic surgery, plastic surgery secrets and procedures, and other cosmetic innovations. Patients and fans can view his surgical transformations on his Instagram, @DrGaryMotykie, which boasts more than 165,000 followers

Share article on social media or email:



Healthcare providers on the front line screening for diabetes, cancer and heart disease; What about addiction?


Join us for this comprehensive two-day conference integrating the latest research in mental health with traditional medical practices. Discussions will focus on how to improve access, engagement, and patient outcomes, giving healthcare practitioners the tools they need to assess behavioral traits before a critical disease state. Conference participation provides continuing medical education (CME) credits and contact hours for students and healthcare practitioners towards state-mandated requirements. This innovative curriculum was developed in partnership with ThriveX™, Axis Medical Education, and Northeast College of Health Science and features a panel of experts addressing the addiction crisis.

To learn more visit and register today: https://thrivex.com/edu

Panel Experts Include:

Michael Sension MD, AAHIVM, CAN Community Health, is an internist and specialist in HIV medicine and is the medical director of Can Community Health in Plantation, Florida. Previously, Dr. Sension was the medical director of HIV Clinical Research for Broward Health in Ft. Lauderdale, Florida. Dr. Sension earned his undergraduate degree from Wheaton College in Wheaton, Illinois, and his medical degree from Johns Hopkins School of Medicine in Baltimore, Maryland. He completed his internship and residency at Cornell University, New York Hospital in New York, New York, and did additional training in infectious diseases at the National Institute of Health in Bethesda, Maryland. He has been the principal investigator of numerous clinical trials and lectures frequently on the topic of HIV treatment and prevention.

Mitchell J. Ghen, DO, Ph.D. has 38 years of experience in anti-aging and holistic and integrative medicine. Along with his work in nutritional medicine, Dr. Mitch has a remarkable amount of experience as an expert clinician and researcher in the field of umbilical cord tissue research. Dr. Mitch holds a Master’s Degree in Biomechanical Trauma and has a Ph.D. in Nutrition and Psychoneuroimmunology.

Antonio De Felippo, MD, Psychiatry, Psychosomatic Medicine, and Addiction Medicine received his medical degree from the University of South Florida Morsani College of Medicine and has been in practice for more than 20 years. He has worked extensively in Addiction, Recovery, and Psychosomatic Medicine. He is presently a pioneer in the treatment of multi-drug-resistant depression and transcranial magnetic stimulation.

Conference Highlights Include:

  • Physical and Psychiatric Co-morbidities that Predispose Patients to SAB
  • Findings in Patients in Recovery
  • Interventional Non-Opiate Pain Management
  • Understanding Different Treatment Programs Available and Proper Documentation and Coding for Clinical Services Rendered.

Share article on social media or email:

SGF research team presents 19 studies at this year’s ASRM Scientific Congress, demonstrating its commitment to continuously improving outcomes for fertility patients


SGF presents 19 studies at this year’s American Society for Reproductive Medicine (ASRM) Scientific Congress & Expo, including a prize paper and 8 oral presentations.

“Year after year, the SGF research team is proud to participate in the ASRM Scientific Congress and Expo and collaborate with reproductive scientists from the U.S. and around the world to improve outcomes for those facing infertility.”

Shady Grove Fertility’s (SGF) physician-scientists will present 19 research abstracts during the 2022 American Society for Reproductive Medicine (ASRM) Scientific Congress & Expo as part of the practice’s commitment to advancing knowledge and improving assisted reproductive technology (ART) treatment outcomes. This year’s research by SGF presented at ASRM covered many important topics care including optimized outcomes for frozen embryo transfers, third-party reproduction, male fertility, and fertility preservation for patients with cancer, to name a few.

Hosted in Anaheim, California, the 78th ASRM Scientific Congress & Expo takes place October 22 through 26, 2022, and attracts more than 8,000 national and international physicians and professionals — distinguished academicians, clinicians, and scientific investigators in the field of human reproduction. The theme of the ASRM 2022 meeting is Genes, Gametes, and Genetics: What Will the Future Hold?

SGF is one of only a few private practice fertility centers in the country to employ a full-time dedicated research team, which operates under Director of Research, Kate Devine, M.D., a board certified reproductive endocrinologist who sees patients at SGF’s Washington, D.C., K Street location. Dr. Devine serves as faculty to fellows at the National Institutes of Health (NIH) training to become reproductive endocrinologists and to residents at Georgetown School of Medicine training to be obstetrician/gynecologists. Dr. Devine also serves as the Executive Medical Director and Chief Research Officer at US Fertility, the largest network of physician-owned and physician-led fertility practices in the United States, of which SGF is a founding partner practice.

“Year after year, the SGF research team is proud to participate in the ASRM Scientific Congress and Expo and collaborate with reproductive scientists from the U.S. and around the world to improve outcomes for those facing infertility,” shares Dr. Devine. “Our research efforts offer hope to those struggling to conceive and push us to continue providing innovative, evidence-based care to fertility patients.”

As a premier IVF and fertility center of excellence, SGF demonstrates a sustained commitment to clinical research and clinical education. Many of the studies presented at the meeting this year resulted from collaborations between SGF and academic institutions. SGF physicians act as clinical instructors and research mentors to physicians in training from NIH, Georgetown University, Eastern Virginia Medical School, University of South Florida, and University of Colorado.

“SGF is proud to be training the next generation of physicians in reproductive medicine,” shares Eric Widra, M.D., Chief Medical Officer, SGF. “Our valuable and unprecedented partnership with our four fellowship programs fuels our research initiatives and gives back to all fertility patients.”    

SGF’s national retrospective cohort study of ovarian response and anti-Mullerian hormone (AMH) in cancer patients undergoing fertility preservation treatment compared to patients who are electively freezing their eggs has been selected as the Fertility Preservation Special Interest Group Prize Paper Prize Paper. The research, led by University of Colorado fellow Ivy Lersten, M.D., alongside her mentor, SGF Colorado physician Cassandra Roeca, M.D., found that the relationship between the number of eggs retrieved or cryopreserved and AMH did not differ for fertility preservation versus elective egg freezing groups. This research can provide reassurance for patients undergoing fertility preservation treatment following a cancer diagnosis.

“At SGF, we know the importance of innovative, evidence-based fertility care,” shares Dr. Roeca. “With this new information, we can better counsel patients and reassure them that their cancer diagnosis does not have to mean the end of their family-building dreams.”

In addition to oral and poster presentations, several SGF physicians and nurses hosted symposiums, interactive sessions, roundtable discussions, and post-graduate courses. Jerrine Morris, M.D., an SGF physician who joined the practice this fall, will lead a roundtable discussion, symposia, and session that all dive into bringing diversity and equity to reproductive healthcare.

To learn more about ongoing research being conducted at SGF, visit http://www.shadygrovefertility.com/research.

About Shady Grove Fertility (SGF)

SGF is a leading fertility and IVF center of excellence with more than 100,000 babies born from 30+ years of continuous innovation and patient-centered fertility care. With 50 locations, including the newest location in Raleigh, North Carolina, as well as throughout CO, FL, GA, MD, NY, PA, TX, VA, D.C., and Santiago, Chile, SGF offers patients in-person and virtual physician consults, delivers individualized care, accepts most insurance plans, and makes treatment affordable through innovative financial options, including 100% refund guarantees. SGF is among the founding partner practices of US Fertility, the largest physician-led partnership of top-tier fertility practices in the U.S. Call 1-888-761-1967 to schedule a new patient appointment or visit ShadyGroveFertility.com for more information.

Share article on social media or email:

Eyedaptic, Inc. unveils the EYE5 glasses with EyeSwitch™


“People value their eyesight over ten times more than any of their other senses. The EYE5 gives my patients with visual impairments access to life-changing technology to enhance their vision,” – Dr. Mitul Mehta, MD Vitreo Retinal Surgeon and Eyedaptic CMO.

Eyedaptic, Inc., is excited to unveil the all-new EYE5 smart glasses at the American Academy of Optometry 2022 Annual Meeting and Expo. Together with Augmented Reality Glasses manufacturer Rokid, Eyedaptic has partnered to deliver a technology solution to an issue biology can’t solve. The latest model brings wearability to a whole new level and covers the widest range of use cases for central vision loss including Diabetic Retinopathy and Age-Related Macular Degeneration (AMD).

Eyedaptic is a Southern California-based developer of game-changing augmented reality eyewear, designed in conjunction with ophthalmology retina specialists and optometrists, to aid those with retinal-related vision challenges. “People value their eyesight over ten times more than any of their other senses. The EYE5 gives my patients with visual impairments access to life-changing technology to enhance their vision. The ability to acquire the smart glasses through their eye care provider makes it more attainable as well” explains Dr. Mitul Mehta, MD Vitreo Retinal Surgeon and Eyedaptic’s Chief Medical Officer.

Equipped with patented simulated natural vision software, the Eyedaptic EYE5 solution optimizes the user’s functional peripheral vision through a small embedded camera that captures an individual’s environment, manipulates and enhances the pixels and re-displays the image, all enabled with hands-free controls. The newest product includes novel artificial intelligence and computer vision algorithms, such as facial detection, to allow the user to see what they have been missing. The newest features integrate seamlessly, while adding powerful technology, to Eyedaptic’s popular custom User Interface. Furthermore, the EYE5 still offers the EyeSwitch 2-in-1 functionality combining a wearable and a hand-held visual aid all in one product, thereby eliminating the need for multiple products for different tasks.

With the availability of Eyedaptic wearables, patients with retinal diseases can now be referred to solutions that enhance their quality of life, easily and unobtrusively. Recently, Eyedaptic was awarded its 6th patent grant. This latest patent extends the technology for Hybrid-See Through, helping to enable Augmented Reality for vision impairments and low vision applications.

Jay Cormier, Eyedaptic CEO says “we are proud to partner with California Bay Area-based Rokid who specializes in the research and product development of Mixed Reality and Artificial Intelligence. With the mission of “leave nobody behind”, Rokid provides the extreme user experience, superior products, and robust enterprise solutions for developing communities. Featuring best-in-class, high-resolution 1080p displays with a wide field of view coupled with a high-resolution autofocus camera, augmented reality has never been more accessible to make a positive and powerful impact on a broad range of industries.”

“Clinical studies have been conducted to demonstrate the utility and efficacy of Eyedaptic smart glasses. The clinical data demonstrated over a doubling in visual acuity and a five times improvement in daily activities. Because Eyedaptic eyewear is designed to be hands-free and not impede mobility, they are ideal for those managing a wide variety of tasks whether it be seeing a movie, grocery shopping, reading a restaurant menu or working at a computer. We are happy to be part of the mission of enhancing vision to revitalize life” says Liang Guan, Rokid North American Vice President and General Manager.

About Rokid

Rokid creates technology that revolutionizes work environments. With innovative products and professional AR solutions for vertical markets, Rokid partners can stand out in the marketplace and foster business growth to serve clients worldwide. For more information, please visit http://www.rokid.ai.

About Eyedaptic

Eyedaptic is a privately held company that develops technology-forward, market-leading wearable visual aid software, enabled by augmented reality hardware, for retinal diseases. The proprietary Simulated Natural Vision software goes beyond magnification to enhance and optimize the field of vision, for those suffering from central vision disorders such as Macular Degeneration, to revitalize their quality of life. For more information, please contact info@eyedaptic.com or visit @eyedaptic on Facebook, Twitter or LinkedIn. #SeeWhatYouveBeenMissing

Share article on social media or email:

How the University of Zagreb School of Medicine (UZSM) moved from conventional microscope histology teaching to online digital teaching with Pathomation


The University of Zagreb School of Medicine (UZSM) adopted Pathomation’s digital pathology for its transformation of microscopy education in 2021, under the impetus of the global COVID-19 pandemic. UZSM opted to incorporate both PMA.core and PMA.slidebox into its microscopy education curriculum, as it made it convenient for students to have both access to (virtual) slide-material during off-hours, as well as for lecturers to offer hands-on teaching materials to students while quarantine and social distancing measures were enforced. UZSM made this transition in the context of limited resources and high time pressure, fully conscious of the perceived disadvantages of digital pathology like implementation complexity, insufficient IT infrastructure and slow image loading experience for users.

“We had been using Pathomation for the European School of Pathology (EScoP) lecture series since 2015, this gave us the confidence that the Pathomation solution could also be used for student distance learning in UZSM.”, recalls Sven Seiwerth, department head and professor of pathology. “It took a global pandemic to move ahead with a broader application into regular teaching”, he laughs, “but we’re very satisfied we’ve made the move; instructors can prepare their lectures in a central secure location, and students tell me the software is really easy to use; all they need is a web browser”.

When asked what his tips for other institutes were that want to start with digital pathology, professor Seiwerh answered “I was most worried about the reaction of my IT department, they were already overloaded due to the pandemic remote work requirements and I thought that integrating digital pathology would be very complex. But the Pathomation software is designed to be integrated in learning environments and the Pathomation team provided great support answering all the questions of our IT department. It only took us two months from start to finish to complete the implementation, the longest part being the scanning of our student’s histopathology collection.”

“The experience of UZSM proves that adopting digital pathology for teaching is within the reach of all and that it can improve students access to teaching.” says Rudy Hovelinck, Pathomation’s Chief Operating Officer Office (COO). “This is a further demonstration that PMA.core and PMA.slidebox are robust and easy to implement products that support a swift transition to digital education. We also continue to expand our offer for academic teaching to meet growing global demands like the recent new release of our My Pathomation online platform.”

About Pathomation: Pathomation was founded in Belgium in 2012. Its free software, PMA.start, has global adaptation and is used at 450+ sites each month. Its online My Pathomation cloud platform hosts a community of 750 users and offers free 10 GB accounts. PMA.core is a clinical diagnostic use CE-IVD certified tile server targeted at any organization that interacts with digital pathology and virtual microscopy data. Pathomation software supports over 35 different proprietary file formats. Visit the company’s website at https://www.pathomation.com/

About UZSM: The School of Medicine in Zagreb is a Croatian medical school affiliated with the University of Zagreb. It is the oldest and biggest of the four medical schools in Croatia, having been established in 1917 and with around 1800 students enrolled in the Croatian MD program, 300 in Medical Studies in English, 60 in the Nurses Master program and more than 1000 in different postgraduate programs. Visit the school’s website at https://www.mef.hr

Share article on social media or email: